Document Detail


Amelioration of metformin-induced hypothyroidism by Withania somnifera and Bauhinia purpurea extracts in Type 2 diabetic mice.
MedLine Citation:
PMID:  19170137     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
An investigation was carried out to reveal the possible ameliorative role of two plant extracts on an antidiabetic drug-induced hypothyroidism in Type 2 diabetic animals. Dexamethasone (1.0 mg/kg, i.m.) administration caused hyperglycemia with a parallel increase in renal lipid peroxidation (LPO), relative risk ratio (RR), and the concentrations of serum insulin; total cholesterol (TC); low-density lipoprotein cholesterol (LDL-C); very low-density lipoprotein cholesterol (VLDL-C) and triglycerides (TG). It decreased serum triiodothyronine (T3), thyroxine (T4) and high-density lipoprotein cholesterol (HDL-C) levels as well as renal superoxide dismutase (SOD); catalase (CAT) and reduced glutathione (GSH) content. Administration with metformin (150 mg/kg, orally) to diabetic animals further reduced circulating T4 level and caused severe hypothyroidism. It also reduced renal LPO, RR, serum concentrations of insulin; glucose and LDL-C with a parallel increase in cellular antioxidants. While oral administration with either Withania somnifera (1.4 g/kg) or Bauhinia purpurea (2.5 mg/kg) extract along with dexamethasone and metformin elevated the concentrations of circulating T3 and T4 to euthyroid level. The plant extracts also corrected RR ratio and serum concentration of lipids. The findings of the present study, for the first time, reveal that the evaluated plant extracts have a potential to ameliorate metformin-induced hypothyroidism in Type 2 diabetic subjects.
Authors:
Rameshwar Jatwa; Anand Kar
Related Documents :
8147947 - Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patien...
12066187 - Subendothelial retention of atherogenic lipoproteins in early atherosclerosis.
20501667 - Impaired-inactivation of foxo1 contributes to glucose-mediated increases in serum very ...
10978257 - Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in famil...
12121337 - Current status of screening for diabetic retinopathy in the uk.
11912547 - Metabolic cardiovascular syndrome in obese prepubertal children: the role of high fasti...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Phytotherapy research : PTR     Volume:  23     ISSN:  1099-1573     ISO Abbreviation:  Phytother Res     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-08-03     Completed Date:  2009-09-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8904486     Medline TA:  Phytother Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  1140-5     Citation Subset:  IM    
Copyright Information:
Copyright 2009 John Wiley & Sons, Ltd.
Affiliation:
Endocrine Research Unit, School of Life Sciences, Devi Ahilya University, Indore, M.P., India-452001. rjatwa80@hotmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Bauhinia / chemistry*
Dexamethasone
Diabetes Mellitus, Experimental / drug therapy
Diabetes Mellitus, Type 2 / drug therapy
Female
Hypothyroidism / chemically induced,  drug therapy*
Metformin
Mice
Plant Bark / chemistry
Plant Extracts / therapeutic use*
Plant Roots / chemistry
Thyroxine / blood
Triiodothyronine / blood
Withania / chemistry*
Chemical
Reg. No./Substance:
0/Plant Extracts; 50-02-2/Dexamethasone; 657-24-9/Metformin; 6893-02-3/Triiodothyronine; 7488-70-2/Thyroxine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Crude cacao theobroma cacao extract reduces mutagenicity induced by benzo[a]pyrene through inhibitio...
Next Document:  Activation of macrophages by polysaccharide-protein complex from Lycium barbarum L.